Tuesday, April 28, 2020 | 4:00 PM EDT - 5:15 PM EDT
Zoom webinar | Margaret Hamburg, Joan Kaufman, Winnie Yip
The arrival of the coronavirus in both China and the United States has further strained an already frayed bilateral relationship. Yet, if the world is to deal with the COVID-19 pandemic and prepare for future health crises, the two nations must work together to confront the immediate issues of medical treatment and equipment, and the longer-term need to develop and produce necessary vaccines.
The National Committee hosted a virtual program on April 28, 2020 with two leading medical experts: Margaret Hamburg of the National Academy of Medicine and Winnie Yip of the Harvard T.H. Chan School of Public Health. The conversation, moderated by Joan Kaufman of Schwarzman Scholars, explored the potential for collaboration between the United States and China on global health strategies.
For more information on the potential economic, social, and political impacts of the coronavirus outbreak, and its long-term implications for U.S.-China relations, please visit our Coronavirus Impact Series.
Margaret “Peggy” Hamburg
Margaret “Peggy” Hamburg is an internationally recognized leader in public health and medicine. She is the former commissioner of the U.S. Food and Drug Administration (FDA), where she served almost six years in the Obama administration. Previous government positions include assistant secretary for planning and evaluation in the U.S. Department of Health and Human Services, health commissioner for New York City, and assistant director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health. Dr. Hamburg currently is foreign secretary at the National Academy of Medicine and recently completed her tenure as president and chair at the American Association for the Advancement of Sciences (AAAS). In addition to her service on the board of the Parker Institute for Cancer Immunotherapy, Hamburg currently sits on the boards of the Simmons Foundation, Commonwealth Fund, Urban Institute, Global Alliance for Vaccines Initiative, and the American Museum of Natural History, as well as the board of directors of Alnylam Pharmaceuticals. Dr. Hamburg earned her B.A. from Harvard College, her M.D. from Harvard Medical School, and completed her medical residency at Weill Cornell Medical Center.
Winnie Yip is professor of global health policy and economics in the department of global health and population at the Harvard T.H. Chan School of Public Health and also director of the school-wide China Health Partnership. Dr. Yip has served as an adviser to the World Bank and the World Health Organization, and notably to the most recent World Bank’s Healthy China study that top Chinese leaders have accepted into their next Five Year Plan on health. She is a senior editor of Social Science and Medicine (Health Policy), associate editor of Health Economics and Health Systems & Reform, and serves on the editorial board for several other health policy publications. Yip has published in top policy and economics journals, such as the Lancet, Health Economics. Her work has been funded by the National Science Foundation, the Bill and Melinda Gates Foundation, the Health Result Innovation Trust Fund (HRITF) of the World Bank, the European Union Commission, and the Economics and Social Science Research Council. Dr. Yip earned her B.A. from the University of California, Berkeley, and her Ph.D. from the Massachusetts Institute of Technology.
Joan Kaufman is the NY–based senior director for academic programs for Schwarzman Scholars. She is a lecturer in global health and social medicine at Harvard Medical School and a visiting professor at Schwarzman College, Tsinghua University, where she teaches global health policy. Dr. Kaufman is also a member of the Council on Foreign Relations. An expert on both China and global health policy, she was the director of Columbia University’s Global Center for East Asia (Beijing) from 2012-2016 and associate professor of health policy and management at Columbia’s Mailman School of Public Health. She was based at Harvard’s Kennedy School of Government from 2002-2010, where she founded and directed the AIDS Public Policy Project and was a faculty affiliate of Harvard’s Hauser Center for Nonprofit Organizations. From 2003-2012 she was a distinguished scientist, senior lecturer, and associate director of the master’s program in health policy and management at Brandeis University’s Heller School for Social Policy and Management. She has lived and worked in China for over 15 years since 1980 including for the Ford Foundation and the United Nations. Dr. Kaufman earned a doctorate in public health from the Harvard T.H. Chan School of Public Health, an M.A. and M.S. (UC Berkeley), and B.A. (Trinity College) cum laude in Chinese studies.